A large study from Umeå University shows that the combination of the two drugs tafamidis and eplontersen for heart amyloidosis does not reduce the risk of death from cardiovascular disease or worsening cardiovascular events, which surprised the researchers. #hjärtamyloidos #Skelleftesjukan #läkemedel (translated)
via.tt.se
Kombination av läkemedel inte hjälpsamt vid Skelleftesjukan
